J. Knegjens

发表

Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy.

Jan-Jakob Sonke, Jose Belderbos, Peter Remeijer, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features.

Liesbeth Boersma, Angela van Baardwijk, Kenneth Gilhuijs, 2012, International journal of radiation oncology, biology, physics.

Prediction of acute toxicity grade ≥ 3 in patients with locally advanced non-small-cell lung cancer receiving intensity modulated radiotherapy and concurrent low-dose Cisplatin.

P. Baas, J. Belderbos, E. van Werkhoven, 2013, Clinical lung cancer.

Tumor Volume as Outcome Predictor in Chemoradiation for Advanced Head and Neck Cancer

F. Hoebers, M. Hauptmann, C. Rasch, 2007 .

Management of radiation oncology patients with a pacemaker or ICD: A new comprehensive practical guideline in The Netherlands

C. Hurkmans, J. Knegjens, L. van Erven, 2012, Radiation oncology.

Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial

C. Faivre-Finn, S. Senan, B. Slotman, 2015, The Lancet.

Diaphragmatic herniation following oesophagectomy

J. V. van Sandick, J. V. van Lanschot, J. Knegjens, 1999, The British journal of surgery.

International Multicenter Randomized Study on Thoracic Radiation Therapy (RT) in Extensive Stage Small Cell Lung Cancer (ES-SCLC): Patterns of Disease Recurrence

C. Faivre-Finn, S. Senan, J. Praag, 2014 .

Randomized trial on thoracic radiotherapy (TRT) in extensive-stage small cell lung cancer.

C. Faivre-Finn, S. Senan, B. Slotman, 2014 .

Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients.

J. Sonke, J. Belderbos, M. Kwint, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases.

H. Klomp, M. Verheij, J. Belderbos, 2017, Lung cancer.

Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial

V. Remouchamps, C. Faivre-Finn, F. Blackhall, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial.

V. Remouchamps, C. Faivre-Finn, F. Blackhall, 2017 .

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.

E. Smit, C. Faivre-Finn, S. Senan, 2017, Lung cancer.

Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating.

J. Aerts, E. Dieleman, M. Verheij, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Tumor volume as prognostic factor in chemoradiation for advanced head and neck cancer

F. Hoebers, M. Hauptmann, R. Wiggenraad, 2010, Head & neck.

The dynamics and prognostic value of FDG PET-metrics in weekly monitoring of (chemo)radiotherapy for NSCLC.

J. Sonke, S. V. van Kranen, J. Knegjens, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

152 Clinical prediction for acute toxicity in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiation

P. Baas, J. Belderbos, M. Kwint, 2012 .

Radiotherapy for extensive stage small-cell lung cancer – Authors' reply

C. Faivre-Finn, S. Senan, B. Slotman, 2015, The Lancet.

HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors.

M. Hauptmann, C. Rasch, A. Begg, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.

Jan-Jakob Sonke, Marcel van Herk, Jasper Nijkamp, 2012, International journal of radiation oncology, biology, physics.

Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.

M. V. van Herk, J. Sonke, J. Belderbos, 2012, International journal of radiation oncology, biology, physics.

Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial.

E. Smit, C. Faivre-Finn, S. Senan, 2017, Lung cancer.

Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating.

J. Aerts, E. Dieleman, M. Verheij, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.